Literature DB >> 23640032

The role of the environment in the development of pediatric inflammatory bowel disease.

Amiirah Aujnarain1, David R Mack, Eric I Benchimol.   

Abstract

The incidence of inflammatory bowel disease (IBD) is rising worldwide, with a particularly sharp increase in children. Rates are highest in North America and Europe, with rapid increases noted in developing nations adopting the Westernized environment. While many genetic risk loci have been identified that predispose people to IBD, incomplete penetrance and overlapping genotypes among patients with different phenotypes inadequately explain the etiology of these chronic diseases. Therefore, environmental risk factors have been the subject of much recent research. This article reviews the role of the environment in IBD, with particular focus on early-life exposures and pediatric-onset disease. The literature surrounding environmental risk factors is reviewed, including prenatal and perinatal exposures, the hygiene hypothesis, the urban environment, infection and antibiotic use, and secondhand tobacco smoke exposure. In addition, the possible role of the environment in altering the intestinal microbiome is addressed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640032     DOI: 10.1007/s11894-013-0326-4

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  83 in total

1.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

2.  Active and passive smoking in childhood is related to the development of inflammatory bowel disease.

Authors:  Suhal S Mahid; Kyle S Minor; Arnold J Stromberg; Susan Galandiuk
Journal:  Inflamm Bowel Dis       Date:  2007-04       Impact factor: 5.325

Review 3.  The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence.

Authors:  Robert G Maunder; Susan Levenstein
Journal:  Curr Mol Med       Date:  2008-06       Impact factor: 2.222

Review 4.  Genetics and pathogenesis of inflammatory bowel disease.

Authors:  Bernard Khor; Agnès Gardet; Ramnik J Xavier
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

5.  A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease.

Authors:  Mark A Feeney; Frank Murphy; Andrew J Clegg; Timothy M Trebble; Nicholas M Sharer; Jonathon A Snook
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-05       Impact factor: 2.566

6.  Appendicectomy, tonsillectomy, and inflammatory bowel disease: a case-control record linkage study.

Authors:  L M Kurina; M J Goldacre; D Yeates; V Seagroatt
Journal:  J Epidemiol Community Health       Date:  2002-07       Impact factor: 3.710

7.  Infectious gastroenteritis and risk of developing inflammatory bowel disease.

Authors:  Chad K Porter; David R Tribble; Pablo A Aliaga; Heather A Halvorson; Mark S Riddle
Journal:  Gastroenterology       Date:  2008-06-05       Impact factor: 22.682

8.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.

Authors:  Xochitl C Morgan; Timothy L Tickle; Harry Sokol; Dirk Gevers; Kathryn L Devaney; Doyle V Ward; Joshua A Reyes; Samir A Shah; Neal LeLeiko; Scott B Snapper; Athos Bousvaros; Joshua Korzenik; Bruce E Sands; Ramnik J Xavier; Curtis Huttenhower
Journal:  Genome Biol       Date:  2012-04-16       Impact factor: 13.583

9.  Common variants at five new loci associated with early-onset inflammatory bowel disease.

Authors:  Marcin Imielinski; Robert N Baldassano; Anne Griffiths; Richard K Russell; Vito Annese; Marla Dubinsky; Subra Kugathasan; Jonathan P Bradfield; Thomas D Walters; Patrick Sleiman; Cecilia E Kim; Aleixo Muise; Kai Wang; Joseph T Glessner; Shehzad Saeed; Haitao Zhang; Edward C Frackelton; Cuiping Hou; James H Flory; George Otieno; Rosetta M Chiavacci; Robert Grundmeier; Massimo Castro; Anna Latiano; Bruno Dallapiccola; Joanne Stempak; Debra J Abrams; Kent Taylor; Dermot McGovern; Gary Silber; Iwona Wrobel; Antonio Quiros; Jeffrey C Barrett; Sarah Hansoul; Dan L Nicolae; Judy H Cho; Richard H Duerr; John D Rioux; Steven R Brant; Mark S Silverberg; Kent D Taylor; M Michael Barmuda; Alain Bitton; Themistocles Dassopoulos; Lisa Wu Datta; Todd Green; Anne M Griffiths; Emily O Kistner; Michael T Murtha; Miguel D Regueiro; Jerome I Rotter; L Philip Schumm; A Hillary Steinhart; Stephen R Targan; Ramnik J Xavier; Cécile Libioulle; Cynthia Sandor; Mark Lathrop; Jacques Belaiche; Olivier Dewit; Ivo Gut; Simon Heath; Debby Laukens; Myriam Mni; Paul Rutgeerts; André Van Gossum; Diana Zelenika; Denis Franchimont; J P Hugot; Martine de Vos; Severine Vermeire; Edouard Louis; Lon R Cardon; Carl A Anderson; Hazel Drummond; Elaine Nimmo; Tariq Ahmad; Natalie J Prescott; Clive M Onnie; Sheila A Fisher; Jonathan Marchini; Jilur Ghori; Suzannah Bumpstead; Rhian Gwillam; Mark Tremelling; Panos Delukas; John Mansfield; Derek Jewell; Jack Satsangi; Christopher G Mathew; Miles Parkes; Michel Georges; Mark J Daly; Melvin B Heyman; George D Ferry; Barbara Kirschner; Jessica Lee; Jonah Essers; Richard Grand; Michael Stephens; Arie Levine; David Piccoli; John Van Limbergen; Salvatore Cucchiara; Dimitri S Monos; Stephen L Guthery; Lee Denson; David C Wilson; Straun F A Grant; Mark Daly; Mark S Silverberg; Jack Satsangi; Hakon Hakonarson
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

10.  Gut microbiomes of Malawian twin pairs discordant for kwashiorkor.

Authors:  Michelle I Smith; Tanya Yatsunenko; Mark J Manary; Indi Trehan; Rajhab Mkakosya; Jiye Cheng; Andrew L Kau; Stephen S Rich; Patrick Concannon; Josyf C Mychaleckyj; Jie Liu; Eric Houpt; Jia V Li; Elaine Holmes; Jeremy Nicholson; Dan Knights; Luke K Ursell; Rob Knight; Jeffrey I Gordon
Journal:  Science       Date:  2013-01-30       Impact factor: 47.728

View more
  30 in total

1.  Response to Fuller-Thomson.

Authors:  Eric I Benchimol; David R Mack; Geoffrey C Nguyen
Journal:  Am J Gastroenterol       Date:  2015-09       Impact factor: 10.864

2.  Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.

Authors:  Yael Haberman; Marina BenShoshan; Ayelet Di Segni; Phillip J Dexheimer; Tzipi Braun; Batia Weiss; Thomas D Walters; Robert N Baldassano; Joshua D Noe; James Markowitz; Joel Rosh; Melvin B Heyman; Anne M Griffiths; Wallace V Crandall; David R Mack; Susan S Baker; Richard Kellermayer; Ashish Patel; Anthony Otley; Steven J Steiner; Ajay S Gulati; Stephen L Guthery; Neal LeLeiko; Dedrick Moulton; Barbara S Kirschner; Scott Snapper; Camila Avivi; Iris Barshack; Maria Oliva-Hemker; Stanley A Cohen; David J Keljo; David Ziring; Yair Anikster; Bruce Aronow; Jeffrey S Hyams; Subra Kugathasan; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2018-01-18       Impact factor: 5.325

3.  Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study.

Authors:  Eric I Benchimol; David R Mack; Astrid Guttmann; Geoffrey C Nguyen; Teresa To; Nassim Mojaverian; Pauline Quach; Douglas G Manuel
Journal:  Am J Gastroenterol       Date:  2015-03-10       Impact factor: 10.864

Review 4.  Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review.

Authors:  Ricardo G Suarez; Alvaro R Osornio-Vargas; Eytan Wine
Journal:  Dig Dis Sci       Date:  2022-06-25       Impact factor: 3.487

Review 5.  Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases.

Authors:  Tatiana Y Fofanova; Joseph F Petrosino; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-02       Impact factor: 2.839

6.  Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.

Authors:  Yael Haberman; Timothy L Tickle; Phillip J Dexheimer; Mi-Ok Kim; Dora Tang; Rebekah Karns; Robert N Baldassano; Joshua D Noe; Joel Rosh; James Markowitz; Melvin B Heyman; Anne M Griffiths; Wallace V Crandall; David R Mack; Susan S Baker; Curtis Huttenhower; David J Keljo; Jeffrey S Hyams; Subra Kugathasan; Thomas D Walters; Bruce Aronow; Ramnik J Xavier; Dirk Gevers; Lee A Denson
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

7.  Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination.

Authors:  Elizabeth Liles; Stephanie A Irving; Padma Dandamudi; Edward A Belongia; Matthew F Daley; Frank DeStefano; Lisa A Jackson; Steven J Jacobsen; Elyse Kharbanda; Nicola P Klein; Eric Weintraub; Allison L Naleway
Journal:  Vaccine       Date:  2021-05-26       Impact factor: 3.641

8.  Exome analysis of patients with concurrent pediatric inflammatory bowel disease and autoimmune disease.

Authors:  Gaia Andreoletti; James J Ashton; Tracy Coelho; Claire Willis; Rachel Haggarty; Jane Gibson; John Holloway; Akshay Batra; Nadeem A Afzal; Robert Mark Beattie; Sarah Ennis
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

9.  Serum Levels of Lipopolysaccharide and 1,3-β-D-Glucan Refer to the Severity in Patients with Crohn's Disease.

Authors:  Yanmin Guo; Guangxi Zhou; Chong He; Wenjing Yang; Zhenkun He; Zhanju Liu
Journal:  Mediators Inflamm       Date:  2015-05-28       Impact factor: 4.711

Review 10.  Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.

Authors:  Bruno Rafael Ramos de Mattos; Maellin Pereira Gracindo Garcia; Julia Bier Nogueira; Lisiery Negrini Paiatto; Cassia Galdino Albuquerque; Caique Lopes Souza; Luís Gustavo Romani Fernandes; Wirla Maria da Silva Cunha Tamashiro; Patricia Ucelli Simioni
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.